Balance Sheet Insights: Edgewise Therapeutics Inc (EWTX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Edgewise Therapeutics Inc (NASDAQ: EWTX) closed at $28.74 down -3.10% from its previous closing price of $29.66. In other words, the price has decreased by -$3.10 from its previous closing price. On the day, 0.56 million shares were traded. EWTX stock price reached its highest trading level at $29.86 during the session, while it also had its lowest trading level at $28.39.

Ratios:

For a deeper understanding of Edgewise Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 26.35 and its Current Ratio is at 26.35. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on November 22, 2024, initiated with a Outperform rating and assigned the stock a target price of $45.

On March 07, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $48.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 24 ’24 when Semigran Marc sold 29,709 shares for $29.69 per share. The transaction valued at 881,915 led to the insider holds 6,716 shares of the business.

MARC J SEMIGRAN bought 50,000 shares of EWTX for $1,499,000 on Dec 24 ’24. On Sep 20 ’24, another insider, Russell Alan J, who serves as the Chief Scientific Officer of the company, sold 75,000 shares for $28.27 each. As a result, the insider received 2,120,101 and left with 12,719 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EWTX now has a Market Capitalization of 2721347328 and an Enterprise Value of 2233252096.

Stock Price History:

Over the past 52 weeks, EWTX has reached a high of $38.12, while it has fallen to a 52-week low of $9.00. The 50-Day Moving Average of the stock is -11.64%, while the 200-Day Moving Average is calculated to be 26.58%.

Shares Statistics:

For the past three months, EWTX has traded an average of 865.21K shares per day and 1129760 over the past ten days. A total of 94.41M shares are outstanding, with a floating share count of 62.41M. Insiders hold about 34.09% of the company’s shares, while institutions hold 74.06% stake in the company. Shares short for EWTX as of 1734048000 were 5642454 with a Short Ratio of 6.52, compared to 1731628800 on 6391944. Therefore, it implies a Short% of Shares Outstanding of 5642454 and a Short% of Float of 8.709999999999999.

Most Popular